BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-10 out of 10 found
  Current Search:  visudyne: 10     

HTML
100%
QLT tops expectations, shares down on outlook
Industry Last Updated: 2010-03-10 18:00:31 -0400 (Reuters Health) * EPS ex items nil vs forecast of $0.10 share loss * Sees 2010 Visudyne sales $90 mln-$100 mln vs $105.7 mln * Punctal plug trial results disappoint * Shares fall 6.25 percent to C$4.80...
Reuters Health:  Mar 11 2010 10:47AM
Matching: visudyne
Find similar documents
HTML
100%
QLT Announces Fourth Quarter and Year End 2009 Results
(GLOBE NEWSWIRE) -- QLT Inc.

(Nasdaq:QLTI) (TSX:QLT) ('QLT' or the 'Company') today reported financial results for the fourth quarter ended December 31, 2009 and full year 2009 as well as issued its guidance for 2010.

Unless specified otherwise, all amounts...

Therapeutics Daily:  Mar 11 2010 9:58AM
Matching: visudyne
Find similar documents
HTML
100%
Combination Therapies for Wet AMD: Latest Developments
PATRIZIA BUCHHOLZ, PhD ANDREAS BUCHHOLZ, MD JANNA KIRCHHOF, PhD ALBERT J.

AUGUSTIN, MD Age-related macular degeneration is the most common cause of vision loss in adult white Americans.

The prevalence of AMD, based on data from population-based...

Retinal Physician:  Mar 11 2010 8:34PM
Matching: visudyne
Find similar documents
HTML
100%
QLT sees big decline in Visudyne sales
_ QLT sees big decline in Visudyne sales.
American Academy of Opthalmology:  Mar 11 2010 9:49AM
Matching: visudyne
Find similar documents
HTML
100%
QLT optimistic about sales of flagship drug, despite decline in revenue
By Sunny Freeman, The Canadian Press QLT Inc.

says it's optimistic about the potential for revenue growth on its Visudyne treatment for age-related blindness despite seeing sales drop even as it divested itself of non-core products last year.

The...

Yahoo! Canada:  Mar 10 2010 7:15PM
Matching: visudyne
Find similar documents
HTML
100%
QLT Announces Fourth Quarter and Year End 2009 Results
"2009 was a success for QLT on many fronts, as we concluded our non-core asset divestments, resolved all outstanding litigation, and amended our Visudyne(R) agreement with Novartis," said Bob Butchofsky, President and Chief Executive Officer of QLT.

"We are...

TradingMarkets:  Mar 10 2010 12:28PM
Matching: visudyne
Find similar documents
HTML
100%
QLT's Q4 profit boosted by sale of U.S. subsidiary
QLT Inc.

says the sale of a U.S.

subsidiary more than offset losses at its continuing operations in the fourth quarter, resulting in a US$80.6-million profit despite declining revenue from its Visudyne treatment for age-related blindness.

The profit...

Bioscience Technology Online:  Mar 10 2010 3:21PM
Matching: visudyne
Find similar documents
HTML
100%
QLT 4Q profit surges on sale of US subsidiary
Canadian drug developer QLT Inc.

said Thursday that its fourth-quarter profit surged on the sale of its U.S.

subsidiary.

The company earned $80.6 million, or $1.49 per share, compared with $5.9 million, or 8 cents per share, in the same quarter a year...

Bioscience Technology Online:  Mar 10 2010 9:49PM
Matching: visudyne
Find similar documents
HTML
100%
QLT Announces Fourth Quarter and Year End 2009 Results
(GLOBE NEWSWIRE) -- QLT Inc.

("QLT" or the "Company") today reported financial results for the fourth quarter ended December 31, 2009 and full year 2009 as well as issued its guidance for 2010.

Unless specified otherwise, all amounts are in U.S.

dollars...

Tech Divas:  Mar 10 2010 6:40PM
Matching: visudyne
Find similar documents
HTML
100%
QLT Announces Fourth Quarter and Year End 2009 Results
(GLOBE NEWSWIRE) -- QLT Inc.

(Nasdaq: QLTI) (TSX: QLT.TO) ("QLT" or the "Company") today reported financial results for the fourth quarter ended December 31, 2009 and full year 2009 as well as issued its guidance for 2010.

Unless specified otherwise, all...

Yahoo! Canada:  Mar 10 2010 1:05PM
Matching: visudyne
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.